Sort
130,381 grants matching “hiv”
Center for Interdisciplinary Research on AIDS
$2,216,839Paul D Cleary · Yale University · P30 · FY2006 · MH
STRENGTHENING THE DELIVERY, COORDINATION AND MONITORING OF HIV SERVICES IN MALAWI
$2,216,386Rose Kumwenda-Ng'oma · Christian Health Association Of Malawi · U2G · FY2010 · PS
Non Human Primate Core
$2,216,373Michael K Axthelm · Oregon Health & Science University · P01 · FY2024 · AI
CCR Genomics Core
$2,216,316Elizabeth Conner · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
A comparative effectiveness trial of extended release naltrexone versus extended-release buprenorphine with individuals leaving jail
$2,216,013Michael Scott Gordon · Friends Research Institute, Inc. · UG1 · FY2021 · DA
HIV PREVENTION PROJECTS
$2,215,318Charles H Woernle · Alabama State Dept Of Public Health · U62 · FY2006 · PS
Search for the Structural Basis of Biomacromolecular Function and Activity
$2,215,225Yun Xing M Wang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Clinical trial of trimethoprim-sulfamethoxazole or chloroquine in adults on ART
$2,214,881Miriam K Laufer · University Of Maryland Baltimore · U01 · FY2011 · AI
HIV Susceptibility and Pathogenesis in the Female Genital Tract
$2,214,520Alan L Landay · Rush University Medical Center · P01 · FY2009 · AI
NIAID Preclinical Development Support
$2,214,078Nancy Lin · Advanced Bioscience Laboratories, Inc. · N01 · FY2014 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,213,189Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Center for Translational Viral Oncology (CTVO)
$2,212,709John T. West · Lsu Health Sciences Center · P20 · FY2023 · GM
Southern Asia HIV/AIDS Clinical Trials Unit
$2,212,534David D. Celentano · Johns Hopkins University · U01 · FY2010 · AI
PS04-012, HIV PREVENTION PROJECTS
$2,212,509Charles H Woernle · Alabama State Dept Of Public Health · U62 · FY2009 · PS
Multilevel strategies to understand and modify the role of structural and environmental context on HIV inequities for sexual and gender minorities of color
$2,211,269H. Jonathon Rendina · George Washington University · UG3 · FY2023 · AI
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$2,210,762Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2017 · AI
Center on Antisocial Drug Dependence: The Genetics of HIV Risk Behaviors
$2,210,188John K Hewitt · University Of Colorado · P60 · FY2009 · DA
Tfh and B cells in HIV/SIV pathogenesis and vaccination
$2,209,941Richard A Koup · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Studies in humans to delineate the basis for viral persistence
$2,209,658David M. Margolis · Univ Of North Carolina Chapel Hill · U19 · FY2014 · AI
Chicago WIHS Consortium V (CWC)
$2,209,223Mardge H Cohen · Hektoen Institute For Medical Research · U01 · FY2016 · AI
Developing Immunogens to Elicit Broadly Neutralizing anti-HIV-1 Antibodies
$2,208,763Pamela J Bjorkman · California Institute Of Technology · P01 · FY2023 · AI
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,207,796Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2012 · CA
Mechanisms Underlying Clearance of Persistent Infections
$2,207,758Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Mirtazapine for methamphetamine use disorder: drug-drug interaction study
$2,205,587Phillip O Coffin · Public Health Foundation Enterprises · U01 · FY2020 · DA
NorthStar Node of the Clinical Trials Network
$2,205,580Gavin Bart · Hennepin Healthcare Research Institute · UG1 · FY2019 · DA